• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中剂量紫外线A1光疗可改善SCORAD指数,并增加白细胞介素-4的mRNA表达,而对人β防御素-1、白细胞介素-10和白细胞介素-31无直接影响。

Medium-dose ultraviolet A1 phototherapy improves SCORAD index and increases mRNA expression of interleukin-4 without direct effect on human β defensin-1, interleukin-10, and interleukin-31.

作者信息

Bogaczewicz Jaroslaw, Malinowska Karolina, Sysa-Jedrzejowska Anna, Wozniacka Anna

机构信息

Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland.

Department of Social Sciences, University of Social Sciences, Lodz, Poland.

出版信息

Int J Dermatol. 2016 Jul;55(7):e380-5. doi: 10.1111/ijd.13213. Epub 2016 Jan 8.

DOI:10.1111/ijd.13213
PMID:26748443
Abstract

BACKGROUND

Effectiveness of ultraviolet (UV)A1 in flares of atopic dermatitis (AD) is thought to influence the expression of cytokines involved in its pathogenesis. The aim of the study was to investigate whether mRNA expression of human β defensin-1 (hβD-1) correlates with that of interleukin (IL)-4, IL-10, and IL-31 in skin lesions in AD before and after UVA1 phototherapy, to determine whether UVA1 decreases the expression of the aforementioned mediators, and to confirm whether changes in mRNA expression correspond with the clinical efficacy of UVA1.

METHODS

Twenty-five patients with AD underwent medium-dose UVA1 phototherapy. Before and after UVA1, biopsies from acute skin lesions were studied using reverse transcription and real-time polymerase chain reaction.

RESULTS

Levels of mRNA hβD-1 correlated with those of IL-10 and IL-31, levels of IL-4 mRNA correlated with those of IL-10 and IL-31, and IL-10 expression correlated with that of IL-31, both before and after UVA1. Phototherapy with UVA1 improved SCORing of Atopic Dermatitis (SCORAD) values, decreased pruritus, and increased expression of IL-4. After UVA1, no difference was found in the mRNA expression of other molecules. The SCORAD index did not correlate with the expression of any examined mRNA either before or after UVA1.

CONCLUSIONS

hβD-1, IL-4, IL-10, and IL-31 are expressed in acute skin lesions in AD, and their levels correlate with each other. UVA1 improves SCORAD and pruritus and increases the expression of IL-4 without direct effect on other molecules.

摘要

背景

长波紫外线A1(UVA1)对特应性皮炎(AD)皮疹的疗效被认为会影响其发病机制中相关细胞因子的表达。本研究旨在探讨UVA1光疗前后AD皮肤损伤中人类β-防御素-1(hβD-1)的mRNA表达与白细胞介素(IL)-4、IL-10和IL-31的mRNA表达是否相关,确定UVA1是否会降低上述介质的表达,并确认mRNA表达的变化是否与UVA1的临床疗效相对应。

方法

25例AD患者接受中剂量UVA1光疗。在UVA1治疗前后,采用逆转录和实时聚合酶链反应对急性皮肤损伤的活检组织进行研究。

结果

UVA1治疗前后,hβD-1的mRNA水平与IL-10和IL-31的水平相关,IL-4的mRNA水平与IL-10和IL-31的水平相关,且IL-10的表达与IL-31的表达相关。UVA1光疗改善了特应性皮炎评分(SCORAD)值,减轻了瘙痒,并增加了IL-4的表达。UVA1治疗后,其他分子的mRNA表达未发现差异。UVA1治疗前后,SCORAD指数与任何检测的mRNA表达均无相关性。

结论

hβD-1、IL-4、IL-10和IL-31在AD的急性皮肤损伤中表达,且它们的水平相互关联。UVA1改善了SCORAD和瘙痒症状,并增加了IL-4的表达,而对其他分子无直接影响。

相似文献

1
Medium-dose ultraviolet A1 phototherapy improves SCORAD index and increases mRNA expression of interleukin-4 without direct effect on human β defensin-1, interleukin-10, and interleukin-31.中剂量紫外线A1光疗可改善SCORAD指数,并增加白细胞介素-4的mRNA表达,而对人β防御素-1、白细胞介素-10和白细胞介素-31无直接影响。
Int J Dermatol. 2016 Jul;55(7):e380-5. doi: 10.1111/ijd.13213. Epub 2016 Jan 8.
2
Medium-dose ultraviolet A1 phototherapy and mRNA expression of TSLP, TARC, IL-5, and IL-13 in acute skin lesions in atopic dermatitis.中剂量紫外线A1光疗与特应性皮炎急性皮肤病变中TSLP、TARC、IL-5和IL-13的mRNA表达
Int J Dermatol. 2016 Aug;55(8):856-63. doi: 10.1111/ijd.12992. Epub 2015 Oct 16.
3
Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.紫外线A1诱导的人β-防御素、白细胞介素-6和白细胞介素-8下调与局限性硬皮病的临床改善相关。
Br J Dermatol. 2006 Sep;155(3):600-7. doi: 10.1111/j.1365-2133.2006.07391.x.
4
Medium dose ultraviolet A1 phototherapy and mRNA expression of interleukin 8, interferon γ, and chemokine receptor 4 in acute skin lesions in atopic dermatitis.中剂量紫外线A1光疗与特应性皮炎急性皮肤损害中白细胞介素8、干扰素γ及趋化因子受体4的mRNA表达
Postepy Dermatol Alergol. 2016 Jun;33(3):170-5. doi: 10.5114/ada.2016.60609. Epub 2016 Jun 17.
5
Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy.特应性皮炎患者在紫外线A1光疗前后细胞因子的基因表达
Br J Dermatol. 2008 May;158(5):1117-20. doi: 10.1111/j.1365-2133.2008.08498.x. Epub 2008 Mar 20.
6
Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.中剂量UVA1光疗治疗特应性皮炎的长期疗效
J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):254-7. doi: 10.1016/S0190-9622(00)90134-8.
7
'High dose' vs. 'medium dose' UVA1 phototherapy in italian patients with severe atopic dermatitis.大剂量与中剂量 UVA1 光疗治疗意大利重症特应性皮炎患者的疗效比较。
J Eur Acad Dermatol Venereol. 2019 Apr;33(4):718-724. doi: 10.1111/jdv.15362. Epub 2018 Dec 28.
8
Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study.中剂量紫外线A1与窄谱中波紫外线光疗治疗特应性皮炎的随机交叉研究
Br J Dermatol. 2009 Mar;160(3):652-8. doi: 10.1111/j.1365-2133.2008.08984.x. Epub 2008 Dec 11.
9
The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis.中剂量UVA1光疗对特应性皮炎患者瘙痒、皮肤病生活质量指数(DLQI)及湿疹面积和严重程度指数(SCORAD)的影响
Postepy Dermatol Alergol. 2020 Dec;37(6):962-967. doi: 10.5114/ada.2019.88465. Epub 2019 Oct 7.
10
Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.紫外线A1光疗可降低局限性硬皮病中抑制性SMAD7基因的表达。
Arch Dermatol Res. 2006 Nov;298(6):265-72. doi: 10.1007/s00403-006-0695-8. Epub 2006 Sep 19.

引用本文的文献

1
IL-31: State of the Art for an Inflammation-Oriented Interleukin.白细胞介素 31:以炎症为导向的白细胞介素的最新研究进展
Int J Mol Sci. 2022 Jun 10;23(12):6507. doi: 10.3390/ijms23126507.
2
Acupuncture for the Treatment of Itch: Peripheral and Central Mechanisms.针灸治疗瘙痒:外周和中枢机制
Front Neurosci. 2022 Mar 30;15:786892. doi: 10.3389/fnins.2021.786892. eCollection 2021.